Ratiopharm Ulm
| Player | PTS | REB | AST | MIN | 2M-2A | 3M-3A | FG% | 1M-1A | FT% | OR | DR | STL | BLK | TO | EFF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 4 | 1 | 23 | 10-11 | 0-0 | 90.9% | 6-7 | 85.7% | 2 | 2 | 0 | 0 | 1 | ||
| 14 | 3 | 2 | 22 | 1-3 | 3-9 | 33.3% | 3-4 | 75.0% | 0 | 3 | 0 | 1 | 2 | ||
| 12 | 6 | 1 | 17 | 5-8 | 0-0 | 62.5% | 2-2 | 100.0% | 3 | 3 | 1 | 3 | 1 | ||
| 8 | 0 | 4 | 21 | 0-1 | 1-1 | 50.0% | 5-5 | 100.0% | 0 | 0 | 0 | 0 | 1 | ||
| 8 | 4 | 1 | 18 | 1-1 | 2-7 | 37.5% | 0-0 | - | 3 | 1 | 0 | 0 | 0 | ||
| 6 | 3 | 5 | 28 | 0-1 | 2-6 | 28.6% | 0-0 | - | 1 | 2 | 2 | 0 | 0 | ||
| 6 | 4 | 0 | 20 | 0-1 | 2-4 | 40.0% | 0-0 | - | 1 | 3 | 1 | 0 | 2 | ||
| 5 | 2 | 2 | 12 | 1-1 | 1-3 | 50.0% | 0-0 | - | 0 | 2 | 0 | 0 | 3 | ||
| 3 | 1 | 0 | 7 | 1-1 | 0-2 | 33.3% | 1-2 | 50.0% | 0 | 1 | 0 | 0 | 0 | ||
| 2 | 5 | 1 | 13 | 1-2 | 0-0 | 50.0% | 0-0 | - | 0 | 5 | 0 | 0 | 3 | ||
| 2 | 0 | 1 | 9 | 1-1 | 0-1 | 50.0% | 0-0 | - | 0 | 0 | 0 | 0 | 1 | ||
| 0 | 0 | 0 | 2 | 0-0 | 0-0 | - | 0-0 | - | 0 | 0 | 0 | 0 | 2 | ||
|
|
92 | 32 | 18 | 21-31 | 11-33 | 50% | 17-20 | 85% | 10 | 22 | 4 | 4 | 16 | 0 |
Eisbären Bremerhaven
| Player | PTS | REB | AST | MIN | 2M-2A | 3M-3A | FG% | 1M-1A | FT% | OR | DR | STL | BLK | TO | EFF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 2 | 4 | 33 | 4-6 | 3-6 | 58.3% | 4-4 | 100.0% | 0 | 2 | 1 | 0 | 0 | ||
| 20 | 10 | 5 | 39 | 5-9 | 2-3 | 58.3% | 4-4 | 100.0% | 4 | 6 | 2 | 0 | 4 | ||
| 17 | 2 | 0 | 16 | 4-8 | 1-3 | 45.5% | 6-6 | 100.0% | 0 | 2 | 0 | 0 | 0 | ||
| 15 | 2 | 1 | 29 | 6-12 | 0-0 | 50.0% | 3-5 | 60.0% | 0 | 2 | 1 | 0 | 2 | ||
| 10 | 4 | 1 | 29 | 5-7 | 0-0 | 71.4% | 0-0 | - | 3 | 1 | 1 | 1 | 1 | ||
| 8 | 0 | 2 | 23 | 3-6 | 0-1 | 42.9% | 2-3 | 66.7% | 0 | 0 | 2 | 0 | 0 | ||
| 7 | 4 | 2 | 17 | 2-5 | 0-1 | 33.3% | 3-4 | 75.0% | 2 | 2 | 0 | 0 | 0 | ||
| 4 | 0 | 0 | 7 | 0-0 | 1-3 | 33.3% | 1-1 | 100.0% | 0 | 0 | 1 | 0 | 0 | ||
| 0 | 1 | 0 | 4 | 0-2 | 0-0 | 0.0% | 0-0 | - | 0 | 1 | 0 | 0 | 1 | ||
|
|
102 | 25 | 15 | 29-55 | 7-17 | 50% | 23-27 | 85.2% | 9 | 16 | 8 | 1 | 8 | 0 |